Research Group: ProNutri: Clinical Nutrition & Disease Programming
Thematic Line: TL1 – Preventive Medicine & Societal Challenges
Hub: NOVA Medical School – Faculty of Medical Sciences of the Nova University of Lisbon
Research Areas: Genetics and Heredity; Research Medicine and Experimental Medicine; Biochemistry and Molecular Biology; Endocrinology and Metabolism; Nutrition and Dietetics
updated on 19/03/2018
Júlio César Rocha is an integrated researcher of the research group ProNutri of CINTESIS.
He graduated in Nutrition from the Faculty of Nutrition and Food Science of the University of Porto, attended the Postgraduate Course in Clinical Nutrition of the same institution and earned his Doctoral Degree in Metabolism – Clinical and Experimental from the Faculty of Medicine of the U.Porto (FMUP).
He began his career as a Professor at the University of Trás-os-Montes and Alto Douro (UTAD), while also teaching undergraduate and postgraduate courses at FMUP.
His interests focus especially on the Phenylketonuria (PKU), a rare genetic disease affecting the metabolism, which treatment basically consists on limiting patients’ protein intake. Júlio César Rocha has published more than 40 articles in scientific journals and won the Honorable Mention of the Sollari Allegro Prize 2016 to Original Scientific Paper published in 2015.
He worked at the Center of Medical Genetics Doctor Jacinto Magalhães (Portuguese acronym, CGMJM) – University Hospital Center of Porto and at the Hospital CUF. He also worked as Guest Assistant Professor at the Fernando Pessoa University. Since 2003 que collaborates with the Mozelos Center of Social Support (Santa Maria da Feira). In 2018 he was invited to integrate the working group responsible for the review of the European Phenylketonuria Guidelines, initially published in 2017. In 2019, he began working at the NOVA Medical School, as Assistant Professor. Also in 2019 he was elected Council Member of the SSIEM – Society for The Study of Inborn Errors of Metabolism.
TITLE: Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach
AUTHORS: Aguiar, A; Ahring, K; Almeida, MF; Assoun, M; Belanger Quintana, AB; Bigot, S; Bihet, G; Blom B Malmberg; Burlina, A; Bushueva, T; Caris, A; Chan, H; Clark, A; Clark, S; Cochrane, B; Corthouts, K; Dalmau, J; Dassy, M; De Meyer, A; Didycz, B; …More
SOURCE: MOLECULAR GENETICS AND METABOLISM, VOLUME: 115, ISSUE: 1, PUBLISHED: 2015
TITLE: Oxidative stress in Phenylketonuria: future directions
AUTHORS: Júlio Cesar Rocha; Maria Joao Martins;
SOURCE: JOURNAL OF INHERITED METABOLIC DISEASE, VOLUME: 35, ISSUE: 3, PUBLISHED: 2012
TITLE: Micronutrient status in phenylketonuria
AUTHORS: Robert, M; Rocha, JC ; van Rijn, M; Ahring, K; Belanger Quintana, A; MacDonald, A; Dokoupil, K; Gokmen G Ozel; Lammardo, AM; Goyens, P; Feillet, F;
SOURCE: MOLECULAR GENETICS AND METABOLISM, VOLUME: 110, ISSUE: SUPPL., PUBLISHED: 2013
TITLE: Is overweight an issue in phenylketonuria?
AUTHORS: Julio C Rocha ; Anita MacDonald; Friedrich Trefz;
SOURCE: MOLECULAR GENETICS AND METABOLISM, VOLUME: 110, ISSUE: SUPPL., PUBLISHED: 2013
TITLE: Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome
AUTHORS: Julio C Rocha; Francjan J van Spronsen; Manuela F Almeida; Gabriela Soares; Dulce Quelhas; Elisabete Ramos; Joao T Guimaraes; Nuno Borges;
SOURCE: MOLECULAR GENETICS AND METABOLISM, VOLUME: 107, ISSUE: 4, PUBLISHED: 2012
Positive Mental Health Program (PMHP)// Programa de Promoção de Saúde Mental Positiva (PPSM+)